Company / R&D per Share
Apyx Medical Corp R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.09
FY2025
5-year range
$0.09 / $0.15
FY2021-FY2025
Trend
-39.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2018 to $0.15 in FY2024.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of -4.0%.
Declined from $0.13 to $0.09 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -12.2%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 39.1% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | -39.1% |
| FY2024 | $0.15 | +11.6% |
| FY2023 | $0.13 | -0.5% |
| FY2022 | $0.13 | +15.5% |
| FY2021 | $0.11 | +4.7% |
| FY2020 | $0.11 | +89.1% |
| FY2019 | $0.06 | +83.8% |
| FY2018 | $0.03 | -55.1% |
| FY2017 | $0.07 | +33.7% |
| FY2016 | $0.05 | -25.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026